Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophrenia

This publication has 40 references indexed in Scilit:

• Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
  Human Molecular Genetics, 2006
• The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery
  Schizophrenia Research, 2006
• Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: A replication study
  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
• Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity
  American Journal of Medical Genetics, 1999
• S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial
  Journal of Hepatology, 1999
• S-adenosylmethionine blood levels in major depression: changes with drug treatment
  Acta Neurologica Scandinavica, 1994
• Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
  Journal of Neurology, Neurosurgery & Psychiatry, 1990
• S-Adenosyl-L-Methionine
  Drugs, 1989
• Affective Illness and S-Adenosyl Methionine
  Clinical Neuropharmacology, 1986
• Age-related modification of dopaminergic and β-adrenergic receptor system: Restoration to normal activity by modifying membrane fluidity with s-adenosylmethionine
  Life Sciences, 1984